Table 1.
Data summary of the participants stratified by AMD phenotype.
| PCV | tAMD | total | P value | |
|---|---|---|---|---|
| (n = 32) | (n = 28) | (n = 60) | ||
| Right eyes (%) | 15 (47%) | 12 (43%) | 27 (45%) | .96† |
| Males (%) | 25 (78%) | 23 (82%) | 48 (80%) | .95† |
| Mean age (±SD)Years | 74.6 (±9.0) | 74.4 (±9.2) | 74.5 (±9.0) | .93* |
| Baseline BCVA LogMAR (±SD) | 0.46 (±0.31) | 0.64 (±0.39) | 0.55 (±0.36) | .053* |
| Baseline CRT (±SD) μm | 414 (±191) | 374 (±109) | 395 (±158) | .34* |
| Baseline GLD (±SD) μm | 4558 (±1712) | 3530 (±996) | 4138 (±1479) | .0068* |
| Subretinal hemorrhage (>1 disc) | 9 (28%) | 5 (18%) | 14 (23%) | .34† |
| BMI | 22.2 (±2.5) | 21.2 (±2.5) | 22.4 (±2.9) | .56* |
| Present or ever smoker | 20 (63%) | 21 (75%) | 41 (68%) | .45† |
| Hypertension | 14 (44%) | 10 (36%) | 24 (40%) | .71† |
| Diabetes mellitus | 5 (16%) | 6 (21%) | 11 (18%) | .81† |
GLD: greatest linear dimension, BCVA: best-corrected visual acuity, CRT: central retinal thickness, and BMI: body mass index. *Unpaired t-test; †×2 test.